Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$10.22 - $13.94 $10,220 - $13,940
-1,000 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$8.42 - $13.96 $4,210 - $6,980
500 Added 100.0%
1,000 $12,000
Q1 2021

May 11, 2021

BUY
$3.2 - $16.51 $1,312 - $6,769
410 Added 455.56%
500 $6,000
Q4 2020

Feb 12, 2021

SELL
$2.92 - $4.84 $3,007 - $4,985
-1,030 Reduced 91.96%
90 $0
Q3 2020

Nov 13, 2020

BUY
$3.03 - $5.48 $3,393 - $6,137
1,120 New
1,120 $4,000
Q2 2020

Aug 12, 2020

SELL
$3.53 - $6.17 $3,177 - $5,553
-900 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$3.53 - $12.21 $1,765 - $6,105
-500 Reduced 35.71%
900 $4,000
Q3 2019

Nov 12, 2019

BUY
$13.91 - $19.87 $19,474 - $27,818
1,400 New
1,400 $22,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.